SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,650,652 | -16.3% | 13,617 | -20.9% | 0.00% | 0.0% |
| Q2 2023 | $1,972,034 | +0.3% | 17,220 | +20.7% | 0.00% | 0.0% |
| Q1 2023 | $1,966,144 | +121042.6% | 14,265 | +13.9% | 0.00% | 0.0% |
| Q4 2022 | $1,623 | -99.9% | 12,527 | -49.6% | 0.00% | -50.0% |
| Q3 2022 | $2,746,000 | +27.2% | 24,844 | -13.8% | 0.00% | 0.0% |
| Q2 2022 | $2,159,000 | -12.3% | 28,806 | -8.6% | 0.00% | +100.0% |
| Q1 2022 | $2,461,000 | -13.5% | 31,502 | -0.2% | 0.00% | -50.0% |
| Q4 2021 | $2,844,000 | -2.2% | 31,580 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $2,908,000 | +33.8% | 31,442 | +12.4% | 0.00% | +100.0% |
| Q2 2021 | $2,174,000 | +2.5% | 27,968 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $2,122,000 | -55.9% | 28,470 | +0.9% | 0.00% | -75.0% |
| Q4 2020 | $4,808,000 | +5.7% | 28,203 | -12.9% | 0.00% | 0.0% |
| Q3 2020 | $4,547,000 | -21.8% | 32,376 | -10.8% | 0.00% | -33.3% |
| Q2 2020 | $5,818,000 | +45.6% | 36,283 | -11.2% | 0.01% | +20.0% |
| Q1 2020 | $3,997,000 | -9.5% | 40,859 | +19.4% | 0.01% | +25.0% |
| Q4 2019 | $4,417,000 | +62.3% | 34,226 | -5.3% | 0.00% | +33.3% |
| Q3 2019 | $2,722,000 | -49.5% | 36,141 | +2.0% | 0.00% | -50.0% |
| Q2 2019 | $5,386,000 | -4.2% | 35,448 | -28.0% | 0.01% | +50.0% |
| Q1 2019 | $5,623,000 | +109.5% | 49,258 | +100.3% | 0.00% | 0.0% |
| Q4 2018 | $2,684,000 | -32.1% | 24,598 | +0.5% | 0.00% | -20.0% |
| Q3 2018 | $3,951,000 | -9.9% | 24,465 | -26.3% | 0.01% | -16.7% |
| Q2 2018 | $4,387,000 | +50.9% | 33,187 | -15.4% | 0.01% | +50.0% |
| Q1 2018 | $2,907,000 | +22.5% | 39,231 | -8.0% | 0.00% | +33.3% |
| Q4 2017 | $2,373,000 | +22.7% | 42,648 | +0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,934,000 | – | 42,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |